Lupartumab Amadotin (BAY 1129980) is an antibody-drug conjugate (ADC) consisting of a fully human C4.4A (LYPD3)-targeting mAb (BAY 1135626) (HY-147281) conjugated to a novel, highly potent derivative of the microtubule-disrupting cytotoxic drug auristatin via a noncleavable alkyl hydrazide linker. Lupartumab Amadotin can be used for the research of non-small cell lung cancer[1].
Purity:
99.61
CAS Number:
[1640972-00-4]
Target:
Antibody-Drug Conjugates (ADCs)
Application Notes:
ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted